It is unknown if the type of general anaesthetic used for maintenance of anaesthesia affects the incidence of postoperative cognitive dysfunction (POCD). The aim of this study was to compare the incidence of POCD in patients administered either sevoflurane or propofol for maintenance of anaesthesia during total hip replacement surgery. Following administration of a spinal anaesthetic, patients received either sevoflurane (n=121) or propofol (n=171) at the discretion of the anaesthetist for maintenance of general anaesthesia to maintain the processed electroencephalogram (bispectral index, BIS) under 60. POCD was assessed postoperatively at day 7, three months, and 12 months using a neurocognitive test battery. There was no statistically significant difference between the incidence of POCD at any timepoint with sevoflurane compared to propofol. The mean BIS was significantly lower in the sevoflurane group than in the propofol group (mean BIS 44.3 [standard deviation, SD, 7.5] in the sevoflurane group versus 53.7 [SD 8.1] in the propofol group, P=0.0001). However, there was no statistically significant association between intraoperative BIS level and the incidence of POCD at any timepoint. Our results suggest that the incidence of POCD is not strongly influenced by the type of anaesthesia used in elderly patients.
1
. With the increased use of target-controlled infusions (TCI) and total intravenous anaesthesia (TIVA) as a practical alternative to inhalational anaesthesia, the question arises as to whether the incidence of POCD differs between these two techniques. This is an important question because the incidence of POCD is more frequent in the elderly, and older patients now represent an ever-increasing proportion of the surgical population 2, 3 . At the present time, in many cases, there is no overwhelming reason to choose inhalational over intravenous anaesthesia, so that a differential cognitive outcome is an important factor to take into account when deciding on anaesthesia technique. Unfortunately, there is little information on how these two techniques compare in terms of postoperative cognitive decline.
The few clinical studies that have investigated this issue have been with small numbers of patients, have often used inappropriate tools to measure cognition, and have produced conflicting results. There is some evidence that in aged rats, sevoflurane increases permeability of the blood-brain barrier during surgery compared to propofol and this is associated with poorer maze negotiation and fear conditioning 4 . For 18-month Wistar rats 1.5 minimum alveolar concentration (MAC) (3.6%) sevoflurane inhalation for two hours exacerbated their cognitive insult, while a lower dose (1.0 MAC) and a mid-dose (1.3 MAC) induced a lesser degree of cognitive insult compared to propofol.
We have previously published the association of preexisting cognitive impairment with POCD in patients undergoing elective hip joint replacement surgery who received spinal anaesthesia in conjunction with general anaesthesia (the trial was registered with the Australian Clinical Trials Registry [ACTRN12607000049471]; registered January 16, 2007; principal investigator B.S.) 5 . In this subanalysis we examined if there was a difference in the incidence of POCD between those patients who received general anaesthesia with sevoflurane versus general anaesthesia with propofol for hip arthroplasty.
Materials and methods
This study was a secondary analysis of the previously published prospective observational study, the Anaesthesia, Cognition, Evaluation (ACE) study. Pre-existing cognitive impairment (PreCI) was defined as a decline of at least two standard deviations (SD) on two or more neuropsychological tests compared to population norms 5 . POCD was defined using the reliable change index 6 . This was defined as when two or more of the eight baseline tests were at least 1.96 SD lower than the mean score of the matched control group after adjusting for expected change over time using controls. In addition, POCD was also defined when the combined Z-score was less than -1.96
The combined Z-score is calculated by dividing the 'Z total score' with the SD of the 'Z total score' in the control group. This 'Z total score' is calculated by summing each 'Z score' in all eight tests, and dividing it by the SD of the combined Z-score in the control group (denominator).
Surgery was undertaken according to usual clinical practice. The orthopaedic surgeon chose either an anterolateral or posterior incision and then performed a standard femoral neck osteotomy. Either a cementless or cemented acetabular component was placed and the femoral prosthesis was then inserted in the intramedullary canal.
Spinal anaesthesia was administered to all patients. The spinal anaesthetic comprised 3.5 to 4 ml 0.5% bupivacaine (isobaric or heavy) injected in the subarachnoid space. Intravenous fentanyl and midazolam were used on indication for sedation and comfort during the procedure. Prior to positioning for surgery, general anaesthesia was induced with propofol and maintained at the anaesthetist's discretion using either a propofol infusion (TIVA) or inhalational sevoflurane. In both cases, bispectral index (BIS) was targeted below 60 and recorded manually every five minutes. The airway was managed as needed with a Hudson mask, laryngeal mask or endotracheal tube. All patients were placed in the lateral position for the purpose of the surgery, which generally helped patients in the propofol group maintain their airway with oxygen administration by Hudson mask, while all of the volatile group patients received a laryngeal mask or endotracheal tube before being placed in the lateral position. Records of BIS and vital signs were kept five-minutely. The average value of BIS recorded during the operative period was used for analysis.
Hypotension (systolic blood pressure less than 100 mmHg or greater than 20% below baseline) was treated by the anaesthetist with a combination of intravenous fluid bolus, metaraminol, ephedrine, or phenylephrine. An arterial line was often placed. In the postoperative period, deep vein thrombosis prophylaxis was performed, and for postoperative analgesia, patient-controlled analgesia with fentanyl or morphine and oral oxycodone was used according to a standardised protocol. During the hospital stay, standard orthopaedic and anaesthetic follow-up occurred and was documented.
Analysis was undertaken using independent t-tests or logistic regression, and chi-square or Fisher's exact test for dichotomous data. A P-value of less than 0.05 was taken to infer statistical significance and 95% confidence intervals were calculated. All statistical analyses were conducted with SAS software, version 9.4 (SAS Institute, Cary, NC, USA).
Results
As described in our previous investigation 5 , 300 patients were enrolled from 1,537 screened; eight participants received sedation only, leaving 292 patients who received general anaesthesia. Of these, 121 received sevoflurane and 171 received propofol. There was a small loss to follow-up at each postoperative testing time. Of the 292 patients, 279 were tested at day 7, 276 at three months and 265 at 12 months.
In the sevoflurane group, the airway was maintained with a laryngeal mask in 98 patients and 23 patients were intubated. In the propofol group, 153 patients were able to maintain an airway and oxygen was administered through a Hudson mask, 17 patients received a laryngeal mask and one patient was intubated. All patients were in a lateral position, aiding airway management with deep sedation and anaesthesia. Table 1 shows the baseline characteristics and Table  2 shows the baseline cognitive test results for both the sevoflurane group and the propofol group. There was no significant difference in neurocognitive test results or MMSE scores between groups at baseline.
There was no significant difference in the duration of anaesthesia between groups. Mean (SD) duration was 141.5 (30.8) minutes in the sevoflurane group and 140.1 (29.1) minutes in the propofol group (P=0.68).
The overall incidence of POCD at seven days was 48/279 (17.2%), at three months 27/276 (9.8%) and at 12 months 7/265 (2.6%). The incidence of POCD in each group is shown in Table 3 . On univariate analysis, there was no statistically significant difference in the incidence of POCD between the sevoflurane and propofol groups at any timepoint (Table 3 and Figure 1 ). For patients assessed at all three timepoints (n=259), POCD was detected in 44 patients (23 sevoflurane versus 21 propofol) at day 7, and of these patients, ten (4 sevoflurane versus 6 propofol) also had POCD at three months, and one (propofol) at 12 months.
The mean (SD) BIS of the sevoflurane group was 44.3 (7.5), which was significantly lower than the propofol group at 53.7 (8.1) (P=0.0001). When adjusted for BIS, there was still no statistically significant difference in the incidence of POCD at any timepoint (Table 3 ). There was no statistically significant association between BIS level and the incidence of POCD (Table 4) .
Discussion
There was no statistically significant difference between patients whose anaesthesia was maintained using sevoflurane versus propofol in the incidence of POCD at seven days, three months or 12 months after total hip joint replacement, although the percentage incidence in the sevoflurane group appeared higher at seven days and lower at three months and 12 months.
The number of studies comparing the incidence of cognitive decline after anaesthesia with volatile agents or propofol is limited. Some studies have compared cognition within the first week after surgery, but assessment at this early time interval is complicated by residual anaesthetic drugs and the stress of surgery. The Nomenclature Consensus Working Group's recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery emphasises that these early changes should not be classified as neurocognitive dysfunction, but recommends the label of delayed neurocognitive recovery to signify that such changes in cognition may be transient 8 . Two studies 9,10 have found cognitive decline at seven days was worse in patients receiving sevoflurane compared to propofol. Consistent with the interpretation of early changes in cognition after anaesthesia and surgery being transient, Cai et al noted that despite early differences in cognition between sevoflurane and propofol these had resolved after ten days 11 . Cognitive function at three months or longer time intervals is generally agreed to have allowed the acute impact of anaesthesia and surgery and postoperative issues to have passed, but there are few studies which have investigated cognition at these time intervals when comparing anaesthetic agents.
There are two studies comparing anaesthesia techniques that have used comprehensive cognitive test batteries to assess cognitive decline from three to 12 months after anaesthesia and surgery. Micha et al randomised 80 patients to receive either sevoflurane or propofol maintenance anaesthesia. They found that in several of the cognitive tests the sevoflurane group declined more than the propofol group at nine months, suggesting that propofol may preserve cognitive function more than sevoflurane 12 . Egawa et al 13 tested cognition three months after randomising 148 patients for lung surgery as part of a study aimed at analysing cerebral oxygenation. They did not find any statistically significant difference in cognition between patients who had received either propofol-or sevoflurane-based anaesthesia.
Liu et al found that sevoflurane compared to propofol lead to a greater progression of cognitive decline in Chinese individuals already diagnosed with amnestic mild cognitive impairment when tested two years after anaesthesia and surgery 14 .
Our results agree with those of Egawa et al, indicating that postoperative cognition is not associated with either sevoflurane or propofol anaesthesia. Indeed, the percentage of individuals who declined at three and/or 12 months was less in the sevoflurane group suggesting that sevoflurane may potentially offer some preservation of cognition at these testing times. Unfortunately, the power of this study is not sufficient to verify this.
There was no statistically significant difference in the incidence of POCD associated with BIS level, despite the mean BIS being significantly lower in the sevoflurane group than in the propofol group. Our findings related to depth of anaesthesia differ from the work of Chan et al 15 , who reported that regardless of type of general anaesthetic, BIS-guided anaesthesia, where a higher BIS was maintained compared with routine anaesthesia, reduced the incidence of POCD at three months postoperatively (10.2% in BIS-guided group versus 14.7% in non BIS-guided group; P-value 0.02). The mean BIS of each group was 53.2 (SD 8.9) and 38.6 (SD 6.5), respectively. In the present study, the mean BIS in the propofol group was 53.7 (SD 8.1) and was significantly higher than the sevoflurane group which was 44.3 (SD 7.5), but this difference in BIS was not associated with an increased incidence of POCD at any timepoint.
The present study is distinguished from previous studies by the large number of patients studied (292), the administration of a comprehensive neuropsychological test battery at specific time intervals up to 12 months, and the use of a control group to calculate the incidence of POCD.
There are some limitations in this study. Firstly, this was an unplanned secondary analysis and the patients were not randomly allocated to either propofol or sevoflurane group. In this study, the choice of the anaesthetic was freely decided by the anaesthetist based on their own preference with the aim of maintaining the BIS less than 60, regardless of anaesthetic choice. Secondly, all patients were administered a spinal anaesthetic prior to general anaesthesia and this was facilitated by a small dose of intravenous midazolam. The sevoflurane group was also given a single induction dose of propofol. It is possible that the midazolam and the intravenous induction in the sevoflurane group may confound the results. However, from a pragmatic point of view, the co-administration of these drugs often occurs, so the results have practical relevance.
In conclusion, we have shown that there was no significant difference in the incidence of POCD between propofol and sevoflurane anaesthesia when given in conjunction with spinal anaesthesia. This study provides evidence that from a cognitive perspective, both sevoflurane and propofol result in a similar incidence of POCD at three and 12 months, although there was a slightly lower incidence of POCD (albeit not statistically significant) associated with the use of sevoflurane at these times. The number of patients studied did not provide sufficient power to detect a difference in the incidence of POCD between anaesthetic groups. Using the incidence of POCD at three months, we calculate from our results that 3,791 patients would be required in each arm to show a significant difference (α=0.05, 1-β=0.8). Considering the thousands of anaesthetics administered every day, the potential long-term consequences of cognitive decline, and that several large randomised controlled trials in anaesthesia have studied thousands of patients 16, 17 , we would recommend a large prospective clinical trial to answer this question.
